Predictive Oncology Inc (POAI) Price to Earnings Ratio

Predictive Oncology Inc - graphic logo of issuer POAI

The share price history of Predictive Oncology (POAI) with the -0.20 metric demonstrates the development of AI tools for selecting anti-tumor drugs. The business relies on steady demand, as digital tests replace costly physical studies during recessionary periods. High profitability is driven by the software scaling of Biopick, where the analysis of cellular reactions on servers eliminates laboratory maintenance costs.

Predictive Oncology Inc. (POAI) - P/E Multiple from 07/04/2022 to 12/12/2025

Analytical breakdowns for Predictive Oncology

- price and consensus price forecast:
Stock Price Predictive Oncology Corp|POAI - Price Target Chart
- market capitalization details:
Market Value Predictive Oncology Inc.|POAI - Real Price to Acquire Entire Company
- book capitalization information:
Accounting Value of a Share Predictive Oncology|POAI - Book Capitalization|Market Capitalization to Book Value predictive-oncology.com|POAI - Aggregate Company Assets
- debt obligations and liquidity statistics:
Debt to Equity Ratio Predictive Oncology|POAI - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient Predictive Oncology Corp|POAI - Company Total Debt|Debt to Book Capital Predictive Oncology Inc.|POAI - Company Long-Term Debt|Company Short-Term Loans and Borrowings Predictive Oncology|Quick Ratio predictive-oncology.com
- earnings and valuation multiples indicators:
POAI - Company Net Income|Future Profit Predictive Oncology|POAI - P/E Multiple|Projected Price to Earnings Ratio Predictive Oncology Corp|POAI - Price/Earnings to Growth Ratio|Enterprise Value to Operating Income Before Depreciation Predictive Oncology Inc.|POAI - Operating profit before deduction of amortization|Earnings per share for the last four quarters Predictive Oncology|POAI - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months predictive-oncology.com|POAI - Earnings per share growth in current year|Net earnings per share change forecast for next year Predictive Oncology
General company analysis:predictive-oncology.com, POAI
Product sample of predictive-oncology.com

Investing in the Predictive Oncology (POAI) AI platform requires evaluating R&D cost efficiency and a high-salaried staff of data scientists through the lens of net profit. By analyzing the business's current P/E ratio, an investor determines the cost of one dollar of earnings, which makes it possible to identify an overpayment for technological potential or confirm the market consensus regarding the monetization rates of the company's bioinformatics developments.

Analysis of competing companies

P/E Multiple intuitive.com|Price to Earnings Ratio Danaher (DHR)|Price to Earnings Ratio BDX (BD)|STERIS Corporation - Price to Earnings Ratio|Company Value to Net Income WST|Baxter International - P/E Multiple|Business Payback Period masimo.com MASI|Stevanato Group (STVN) - Price to Earnings Ratio|Price to Earnings Multiple TFX|Price to Earnings Ratio Merit Medical Systems Inc|Nobel Biocare (NVST) - Business Payback Period|Price to Earnings Ratio ICUI (ICU Medical, Inc.)|Market Price to Net Income Ratio XRAY|Price to Earnings Ratio LeMaitre Vascular LMAT|Company Value to Net Income ATRC|STAA: Price to Earnings Ratio|NAGE - P/E Multiple|ZimVie Inc. (ZIMV) - Price to Earnings Ratio|Price to Earnings Ratio angiodynamics.com|CERS (Cerus) - P/E Multiple|Market Cap to Earnings Alpha Teknova TKNO|Price to Earnings Ratio Monogram Technologies Inc (MGRM)|sharpstechnology.com - Price to Earnings Multiple|InfuSystem Holdings, Inc. - Price to Earnings Ratio|Market Price to Net Income Ratio UTMD (utahmed.com)|KRMD - Price to Earnings Ratio|Business Payback Period Nyxoah SA NYXH|Microbot Medical Inc (MBOT) - Price to Earnings Ratio|Market Cap to Net Income PDEX (Pro-Dex Inc.)|Price to Earnings Ratio Zentek Ltd.|ELUT: Company Value to Net Income|P/E Multiple MLSS|NXGL - Market Cap to Earnings|P/E Multiple RVP (Retractable Technologies, Inc.)|HBIO: Price to Earnings Multiple|Femasys Inc. - P/E Multiple|Business Payback Period MeihuaMed MHUA|CJMB: P/E Multiple|Price to Earnings Ratio Atrion Corp.|Price to Earnings Ratio NURO